30 aa
Predicted · Cα pLDDT 90.5 / 100
Completion observed (Asia/Shanghai):
Static model
PAE · Å
PAE image is unavailable.
pTM 0.46
A few molecular notes beside a poem.
LETTHERAINWRITEACLEARERPATTERN
These model readings are not real-world event rates; suitability for this peptide has not been validated.
Modelled molecular behavior
Each endpoint keeps its own 0–1 model output; these are not cross-endpoint rankings.
Absorption & transport
- Intestinal absorption · HIA
- 0.15
- Oral bioavailability
- 0.40
- Blood–brain barrier · BBB
- 0.25
- P-gp
- 0.41
Metabolism · CYP
Safety-related assays
- Ames assay
- 0.22
- Drug-induced liver injury · DILI
- 0.45
- hERG channel
- 0.60
Reading notes & six additional results
Classification outputs are uncalibrated; they do not establish individual event probabilities or safety.
Method: TabPFN2.5 · tdc22_v1
Result observed at:
Chemical form: linear L-peptide, with free, neutral termini and side chains.
Units and numerical scales for these six endpoints remain unconfirmed; the model readings are retained below.
- Caco-2
- -6.97
- Hepatocyte clearance
- 30.39
- Microsomal clearance
- 57.54
- Half-life
- 21.28
- Plasma protein binding
- 70.92
- Distribution volume
- 1.25
Readings retain the scale returned for each endpoint; no conversion to linear physical quantities has been made. Glyphs identify endpoints, not measurement axes.